This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Medtronic PLC (MDT)

NYSE: Health Care

Company Cash Flow
Apr 2015 Apr 2014 Apr 2013 Apr 2012
Cash Flow From Operating Activities
Net Income (Loss) 2.67B 3.06B 3.47B 0.00
Operating Gains/Losses 0.00 0.00 0.00 -218.00M
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -413.00M -70.00M 1.00M -252.00M
(Increase) Decrease in Inventories -282.00M -39.00M 93.00M -185.00M
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables 1.62B -117.00M 422.00M 300.00M
(Decrease) Increase In Other Current Liabilities 0.00 0.00 0.00 0.00
(Increase) Decrease In Other Working Capital 643.00M 444.00M -215.00M 155.00M
Other Non-Cash Items 207.00M 1.02B 199.00M 3.74B
Net Cash From Continuing Operations 4.90B 4.96B 4.88B 4.47B
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 4.90B 4.96B 4.88B 4.47B
Sale of Property, Plant & Equipment 0.00 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00 6.10B
Purchases of Property, Plant & Equipment -571.00M -396.00M -457.00M -499.00M
Acquisitions -14.88B -385.00M -820.00M -170.00M
Purchases of Short-Term Investments 0.00 0.00 0.00 -8.08B
Other Cash from Investing Activities 89.00M -29.00M -14.00M -6.00M
Cash Provided by Financing Activities
Net Cash From Investing Activities -17.06B -3.59B -3.10B -2.65B
Issuance of Debt 20.09B 3.17B 5.61B 625.00M
Cash Used for Financing Activities
Issuance of Capital Stock 649.00M 1.31B 267.00M 96.00M
Repayment of Long-Term Debt -1.42B -1.87B -4.91B -24.00M
Repurchase of Capital Stock -1.92B -2.55B -1.25B -1.44B
Payment of Cash Dividends -1.34B -1.12B -1.05B -1.02B
Other Financing Charges, Net -117.00M 140.00M -760.00M -118.00M
Net Cash From Financing Activities 15.95B -918.00M -2.10B -1.88B
Effect of Exchange Rate Changes -353.00M 37.00M 7.00M -71.00M
Net Change in Cash & Cash Equivalents 3.44B 484.00M -312.00M -134.00M
MDT News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

Analysts Ratings for MDT

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 12 11 11 11
Moderate Buy 2 2 2 1
Hold 4 4 4 4
Moderate Sell 0 0 0 0
Strong Sell 1 1 0 0

MDT Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs